questionsmedicales.fr
Disciplines et activités comportementales
Tests psychologiques
Tests neuropsychologiques
Échelles d'évaluation en psychiatrie
Échelles d'évaluation en psychiatrie : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Échelles d'évaluation en psychiatrie : Questions médicales les plus fréquentes",
"headline": "Échelles d'évaluation en psychiatrie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Échelles d'évaluation en psychiatrie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-14",
"dateModified": "2025-03-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Échelles d'évaluation en psychiatrie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tests neuropsychologiques",
"url": "https://questionsmedicales.fr/mesh/D009483",
"about": {
"@type": "MedicalCondition",
"name": "Tests neuropsychologiques",
"code": {
"@type": "MedicalCode",
"code": "D009483",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.711.513"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Échelle abrégée d'appréciation psychiatrique",
"alternateName": "Brief Psychiatric Rating Scale",
"url": "https://questionsmedicales.fr/mesh/D010054",
"about": {
"@type": "MedicalCondition",
"name": "Échelle abrégée d'appréciation psychiatrique",
"code": {
"@type": "MedicalCode",
"code": "D010054",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.711.513.653.083"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Questionnaire sur l'état mental de Kahn",
"alternateName": "Mental Status Schedule",
"url": "https://questionsmedicales.fr/mesh/D008609",
"about": {
"@type": "MedicalCondition",
"name": "Questionnaire sur l'état mental de Kahn",
"code": {
"@type": "MedicalCode",
"code": "D008609",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.711.513.653.574"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Échelles d'évaluation en psychiatrie",
"alternateName": "Psychiatric Status Rating Scales",
"code": {
"@type": "MedicalCode",
"code": "D011569",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Andreas B Hofmann",
"url": "https://questionsmedicales.fr/author/Andreas%20B%20Hofmann",
"affiliation": {
"@type": "Organization",
"name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Psychiatry, Psychotherapy and Psychosomatics, Zurich, Switzerland."
}
},
{
"@type": "Person",
"name": "Hanna M Schmid",
"url": "https://questionsmedicales.fr/author/Hanna%20M%20Schmid",
"affiliation": {
"@type": "Organization",
"name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Psychiatry, Psychotherapy and Psychosomatics, Zurich, Switzerland."
}
},
{
"@type": "Person",
"name": "Mounira Jabat",
"url": "https://questionsmedicales.fr/author/Mounira%20Jabat",
"affiliation": {
"@type": "Organization",
"name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Psychiatry, Psychotherapy and Psychosomatics, Zurich, Switzerland."
}
},
{
"@type": "Person",
"name": "Nathalie Brackmann",
"url": "https://questionsmedicales.fr/author/Nathalie%20Brackmann",
"affiliation": {
"@type": "Organization",
"name": "University of Zurich, Faculty of Medicine, Psychiatric University Hospital of Zurich, Department of Forensic Psychiatry, Zurich, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs.",
"datePublished": "2022-11-19",
"url": "https://questionsmedicales.fr/article/36432713",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/pharmaceutics14112523"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ovarian resection in anti-N-methyl-D-aspartate receptor encephalitis: A comparison of surgical approaches.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36468045",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fneur.2022.1043785"
}
},
{
"@type": "ScholarlyArticle",
"name": "Overexpression of transient receptor potential melastatin 6 during human oral squamous cell carcinogenesis.",
"datePublished": "2022-11-14",
"url": "https://questionsmedicales.fr/article/36643266",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jds.2022.11.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Landscape of potentially targetable receptor tyrosine kinase fusions in diverse cancers by DNA-based profiling.",
"datePublished": "2022-11-11",
"url": "https://questionsmedicales.fr/article/36369474",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41698-022-00325-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Influence of extensive use of a photostimulable phosphor receptor on the diagnosis of proximal carious lesions: An in vitro study.",
"datePublished": "2022-11-11",
"url": "https://questionsmedicales.fr/article/36566136",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.oooo.2022.11.004"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tests psychologiques",
"item": "https://questionsmedicales.fr/mesh/D011581"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tests neuropsychologiques",
"item": "https://questionsmedicales.fr/mesh/D009483"
},
{
"@type": "ListItem",
"position": 5,
"name": "Échelles d'évaluation en psychiatrie",
"item": "https://questionsmedicales.fr/mesh/D011569"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Échelles d'évaluation en psychiatrie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Échelles d'évaluation en psychiatrie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Échelles d'évaluation en psychiatrie",
"description": "Qu'est-ce qu'une échelle d'évaluation psychiatrique ?\nComment sont-elles utilisées dans le diagnostic ?\nQuels types de troubles peuvent être évalués ?\nQui peut administrer ces échelles ?\nSont-elles standardisées ?",
"url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=ErbB+Receptors&page=998#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Échelles d'évaluation en psychiatrie",
"description": "Quels symptômes mesurent-elles ?\nPeuvent-elles évaluer la sévérité des symptômes ?\nComment les symptômes sont-ils notés ?\nY a-t-il des échelles pour les enfants ?\nLes symptômes peuvent-ils fluctuer ?",
"url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=ErbB+Receptors&page=998#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Échelles d'évaluation en psychiatrie",
"description": "Peuvent-elles aider à la prévention des troubles ?\nComment sont-elles utilisées en prévention ?\nY a-t-il des échelles spécifiques pour la prévention ?\nPeuvent-elles évaluer le stress ?\nSont-elles utiles pour les populations à risque ?",
"url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=ErbB+Receptors&page=998#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Échelles d'évaluation en psychiatrie",
"description": "Comment les échelles influencent-elles le traitement ?\nPeuvent-elles prédire la réponse au traitement ?\nSont-elles utilisées pour suivre l'évolution ?\nPeuvent-elles évaluer l'efficacité d'un traitement ?\nLes échelles sont-elles adaptées à tous les traitements ?",
"url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=ErbB+Receptors&page=998#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Échelles d'évaluation en psychiatrie",
"description": "Quelles complications peuvent survenir sans évaluation ?\nLes échelles aident-elles à prévenir les complications ?\nPeuvent-elles identifier des comorbidités ?\nComment les complications sont-elles évaluées ?\nLes complications affectent-elles le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=ErbB+Receptors&page=998#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Échelles d'évaluation en psychiatrie",
"description": "Quels facteurs de risque sont évalués ?\nLes échelles mesurent-elles l'impact des facteurs environnementaux ?\nPeuvent-elles identifier des comportements à risque ?\nComment les facteurs de risque influencent-ils le traitement ?\nLes facteurs de risque sont-ils modifiables ?",
"url": "https://questionsmedicales.fr/mesh/D011569?mesh_terms=ErbB+Receptors&page=998#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Qu'est-ce qu'une échelle d'évaluation psychiatrique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un outil pour quantifier les symptômes et évaluer l'état mental."
}
},
{
"@type": "Question",
"name": "Comment sont-elles utilisées dans le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles aident à établir un diagnostic précis en mesurant les symptômes."
}
},
{
"@type": "Question",
"name": "Quels types de troubles peuvent être évalués ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent évaluer des troubles comme la dépression, l'anxiété, et la schizophrénie."
}
},
{
"@type": "Question",
"name": "Qui peut administrer ces échelles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être administrées par des professionnels de santé qualifiés."
}
},
{
"@type": "Question",
"name": "Sont-elles standardisées ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent standardisées pour assurer la fiabilité des résultats."
}
},
{
"@type": "Question",
"name": "Quels symptômes mesurent-elles ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles mesurent des symptômes comme l'humeur, l'anxiété, et les comportements."
}
},
{
"@type": "Question",
"name": "Peuvent-elles évaluer la sévérité des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles évaluent la sévérité des symptômes pour guider le traitement."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils notés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes sont notés sur une échelle numérique ou descriptive."
}
},
{
"@type": "Question",
"name": "Y a-t-il des échelles pour les enfants ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines échelles sont spécifiquement conçues pour les enfants et adolescents."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils fluctuer ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon les circonstances et le temps."
}
},
{
"@type": "Question",
"name": "Peuvent-elles aider à la prévention des troubles ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent identifier des symptômes précoces et aider à la prévention."
}
},
{
"@type": "Question",
"name": "Comment sont-elles utilisées en prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont utilisées pour détecter des signes précoces et orienter les interventions."
}
},
{
"@type": "Question",
"name": "Y a-t-il des échelles spécifiques pour la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines échelles sont spécifiquement conçues pour évaluer le risque de troubles."
}
},
{
"@type": "Question",
"name": "Peuvent-elles évaluer le stress ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines échelles mesurent le stress, un facteur de risque pour les troubles."
}
},
{
"@type": "Question",
"name": "Sont-elles utiles pour les populations à risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont particulièrement utiles pour les populations à risque élevé."
}
},
{
"@type": "Question",
"name": "Comment les échelles influencent-elles le traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles aident à adapter le traitement en fonction de l'évolution des symptômes."
}
},
{
"@type": "Question",
"name": "Peuvent-elles prédire la réponse au traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines échelles peuvent aider à prédire la réponse au traitement en cours."
}
},
{
"@type": "Question",
"name": "Sont-elles utilisées pour suivre l'évolution ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent utilisées pour suivre l'évolution des symptômes au fil du temps."
}
},
{
"@type": "Question",
"name": "Peuvent-elles évaluer l'efficacité d'un traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent d'évaluer l'efficacité des interventions thérapeutiques."
}
},
{
"@type": "Question",
"name": "Les échelles sont-elles adaptées à tous les traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être adaptées à divers traitements, mais pas tous les types."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans évaluation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans évaluation, des complications comme l'aggravation des symptômes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les échelles aident-elles à prévenir les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent d'identifier les problèmes avant qu'ils ne s'aggravent."
}
},
{
"@type": "Question",
"name": "Peuvent-elles identifier des comorbidités ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines échelles peuvent aider à identifier des comorbidités psychiatriques."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles évaluées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont évaluées par des scores et des descriptions des symptômes associés."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles le traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent nécessiter des ajustements dans le traitement."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont évalués ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent l'hérédité, le stress et les antécédents médicaux."
}
},
{
"@type": "Question",
"name": "Les échelles mesurent-elles l'impact des facteurs environnementaux ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent évaluer l'impact des facteurs environnementaux sur la santé mentale."
}
},
{
"@type": "Question",
"name": "Peuvent-elles identifier des comportements à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines échelles peuvent identifier des comportements à risque liés à la santé mentale."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque influencent-ils le traitement ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent influencer le choix du traitement et la stratégie d'intervention."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque sont-ils modifiables ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains facteurs de risque, comme le stress, peuvent être modifiés par des interventions."
}
}
]
}
]
}
Targeting selective estrogen subtype receptors through typical medicinal chemistry approaches is based on occupancy-driven pharmacology. In occupancy-driven pharmacology, molecules are developed in or...
For patients with anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) and ovarian teratoma, "conservative" surgical approaches (complete or partial unilateral oophorectomy or bilateral partial oo...
To compare the one-year functional outcomes of patients with NMDARE who underwent conservative vs. aggressive ovarian resections....
Patients with NMDARE undergoing ovarian resection between January 1st, 2012 and December 31st, 2021 were retrospectively identified from three North American tertiary care centers. Primary outcome was...
Twenty-three patients were included. Eight underwent aggressive surgical management. There was a non-significant trend toward an association between aggressive surgical management and younger age-at-o...
Aggressive ovarian resection was not associated with improved outcomes in patients with NMDARE in this series. Group differences may have contributed, recognizing that patients who underwent aggressiv...
Transient receptor potential melastatin (TRPM) channel is involved in cell proliferation and cell survival. Eight members (TRPM1-8) are within the TRPM subfamily. The current study is aimed to investi...
Sixty-six oral squamous cell carcinomas (OSCCs), 47 oral potentially malignant disorders (OPMD) with moderate-severe epithelial dysplasia (ED), 28 OPMD with mild ED, and 33 normal oral mucosa (NOM) sa...
TRPM6 protein expression in OSCC was significantly increased as compared with normal samples. Protein expression of TRPM6 in OCCLs was significantly higher as compared with HOK. Significant decreases ...
Our results implicate that TRPM6 overexpression is potentially related to human oral carcinogenesis....
Recurrent fusions of receptor tyrosine kinases (RTKs) are often driving events in tumorigenesis that carry important diagnostic value and are potentially targetable by the increasing number of tyrosin...
The aim of this study was to evaluate the influence of the extensive use of a photostimulable phosphor (PSP) receptor on the diagnosis of proximal carious lesions....
Forty posterior teeth were paired and mounted in 20 phantoms. Using a PSP receptor of the Express intraoral system, 1 radiograph of each phantom was acquired, totaling 20 radiographs (group 1). After ...
The diagnostic outcomes for proximal caries did not differ among the groups (P ≥ .37). The diagnostic values did not differ among the radiographs acquired with the 2 PSP receptors (P ≥ .75)....
The diagnosis of proximal carious lesions was not affected by extensive use of the PSP receptor....
Interstitial cystitis/bladder pain syndrome is a chronic inflammatory pelvic pain syndrome of unknown etiology characterized by a number of lower urinary tract symptoms, including increased urinary ur...
A series of substituted imidazoquinolines, a structurally related chemotype to pyrazoloquinolinones, a well-known class of GABA...
The online version contains supplementary material available at 10.1007/s00706-022-02988-8....
Activin receptor type IIA and type IIB fusion protein have been designed to sequester circulating molecules of the transforming growth factor-β (TGF-β) superfamily and inactivate their actions. Member...
CC chemokine receptor type-2 (CCR2) belongs to the G protein-coupled receptors superfamily, and is localized on cell surface of tumor cells and some immune cells, including monocytes and macrophages. ...
Protein tyrosine phosphatase receptor-type kappa (PTPRK) is a transmembrane receptor that links extracellular homophilic interactions to intracellular catalytic activity. Previously we showed that PTP...